RECENT BLOGS POSTS
RECENT ADDED NEWS
-
REPROCELL and Histocell Achieve GMP Certification for Manufacturing Process of Clinical-Grade iPSC Master and Working Cell Banks Using StemRNA™ Clinical iPSCsNews20/10/2025 REPROCELL and Histocell Achieve GMP Certification for Manufacturing Process of Clinical-Grade iPSC Master and Working Cell Banks Using StemRNA™ Clinical iPSCsREPROCELL (Yokohama, Japan; TYO: 4978) and Histocell (Bilbao, Spain) are proud to announce... -
10/05/2024 Histocell receives the “Enpresan Bardin” award from CEBEK for its equality policies.On May 8, Histocell received the "Enpresan Bardin" award for its work in...
-
Histocell obtains AEMPS authorisation and GMP certification for its new manufacturing plant for cell therapy and associated biological medicinal products in Larrabetzu.News25/01/2024 Histocell obtains AEMPS authorisation and GMP certification for its new manufacturing plant for cell therapy and associated biological medicinal products in Larrabetzu.The biopharmaceutical company reaffirms its commitment to local innovation and manufacturing with the... -
REPROCELL offers mesenchymal stem cell based CDMO services to manufacture Advanced Therapies Medicinal ProductsNews24/05/2023 REPROCELL offers mesenchymal stem cell based CDMO services to manufacture Advanced Therapies Medicinal ProductsYokohama Japan, 24 May 2023 REPROCELL will now offer CDMO services to manufacture... -
Histocell takes part in the new European project NABIHEAL in biomaterials for complex wound healingNews17/01/2023 Histocell takes part in the new European project NABIHEAL in biomaterials for complex wound healingThe Horizon Europe project NABIHEAL, coordinated by the Center for Biomedical Research Network... -
Histocell leads ITEAS project: industrial research to boost advanced therapies in the Basque CountryNews19/12/2022 Histocell leads ITEAS project: industrial research to boost advanced therapies in the Basque CountryThe ITEAS project investigates advanced therapy drugs to generate new therapeutic strategies for...
